Abstract
Retrograde ureterorenoscopy (URS) is a standard treatment approach for renal and ureteral stones, as well as for other upper tract pathology like ureteral stricture disease and transitional cell carcinoma. Obese patients present unique challenges for treatment of stone disease in particular, as shock wave lithotripsy (SWL) has a higher risk of failure in these patients, and percutaneous nephrolithotomy (PNL) may present technical challenges based on large body habitus. URS, then, may be the preferred approach in patients with significant obesity, though there may be anesthesia and surgical challenges to this procedure as well. URS may also be the treatment of choice in patients with bleeding disorders, or those who are anticoagulated, based on bleeding risks associated with alternative modalities (e.g., SWL and PNL). Refinements in ureteroscope and laser technology have enabled safe therapeutic interventions in this population despite their propensity for bleeding. Care to minimize trauma to the upper tract during these interventions is necessary to ensure treatment safety and efficacy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Wang AJ, Preminger GM. Modern applications of ureteroscopy for intrarenal stone disease. Curr Opin Urol. 2011;21(2):141–4.
Bader MJ, Sroka R, Gratzke C, et al. Laser therapy for upper urinary tract transitional cell carcinoma: indications and management. Eur Urol. 2009;56(1):65–71.
Patel RC, Newman RC. Ureteroscopic management of ureteral and ureteroenteral strictures. Urol Clin North Am. 2004;31(3):107–13.
Ogden CL, Yanovski SZ, Carroll MD, et al. The epidemiology of obesity. Gastroenterology. 2007;132:2087–102.
Duffey BG, Pedro RN, Kriedberg C, et al. Lithogenic risk factors in the morbidly obese population. J Urol. 2008;179:1401–6.
Delakas D, Karyotis I, Daskalopoulos G, et al. Independent predictors of failure of shockwave lithotripsy for ureteral stones employing a second-generation lithotripter. J Endourol. 2003;17(4):201–5.
El-Nahas AR, El-Assmy AM, Mansour O, et al. A prospective multivariate analysis of factors predicting stone disintegration by extracorporeal shock wave lithotripsy: the value of high-resolution noncontrast computed tomography. Eur Urol. 2007;51(6):1888–93.
Pearle MS, Nakada SY, Womack S, et al. Outcomes of contemporary percutaneous nephrostolithotomy in morbidly obese patients. J Urol. 1998;160:669–73.
Faerber GJ, Goh M. Percutaneous nephrolithotripsy in the morbidly obese patient. Tech Urol. 1997;3:89–95.
Manohar T, Jain P, Desai M. Supine percutaneous nephrolithotomy: effective approach to high-risk and morbidly obese patients. J Endourol. 2007;21(1):44–9.
Kerbl K, Clayman RV, Chandhoke PS, et al. Percutaneous stone removal with the patient in a flank position. J Urol. 1994;151(3):686–8.
Kanaroglou A, Razvi H. Percutaneous nephrolithotomy under conscious sedation in morbidly obese patients. Can J Urol. 2006;13(3):3153–5.
El-Assmy AM, Shokeir AA, El-Nahas AR, et al. Outcome of percutaneous nephrolithotomy: effect of body mass index. Eur Urol. 2007;52:199–204.
Tomaszewski JJ, Smaldone MC, Schuster T, et al. Outcomes of percutaneous nephrolithotomy stratified by body mass index. J Endourol. 2010;24(4):547–50.
Koo BC, Burtt G, Burgess NA. Percutaneous stone surgery in the obese: outcome stratified according to body mass index. BJU Intl. 2004;93:1296–9.
Bagrodia A, Gupta A, Raman JD, et al. Impact of body mass index on cost and clinical outcomes after percutaneous nephrostolithotomy. Urology. 2008;72:756–60.
Sergeyev I, Koi PT, Jacobs SL, et al. Outcome of percutaneous surgery stratified according to body mass index and kidney stone size. Surg Laparosc Endosc Percutan Tech. 2007;17(3):179–83.
Turney BW, Reynard JM, Noble JG, et al. Trends in urological stone disease. BJU Int. 2012;109(7):1082–7.
Patel T, Kozakowski K, Hruby G, et al. Skin to stone distance is an independent predictor of stone-free status following shockwave lithotripsy. J Endourol. 2009;23(9):1383–5.
Andreoni C, Afane J, Olweny E, et al. Flexible ureteroscopic lithotripsy: first-line therapy for proximal ureteral and renal calculi in the morbidly obese and superobese patient. J Endourol. 2001;15(5):493–8.
Fabrizio MD, Behari A, Bagley DH. Ureteroscopic management of intrarenal calculi. J Urol. 1998;159:1139–43.
Ricchiuti DJ, Smaldone MC, Jacobs BL, et al. Staged retrograde endoscopic lithotripsy as alternative to PCNL in select patients with large renal calculi. J Endourol. 2007;21(12):1421–4.
Hyams ES, Munver R, Bird VG, et al. Flexible ureterorenoscopy and Holmium laser lithotripsy for the management of renal stone burdens that measure 2 to 3 cm: a multi-institutional experience. J Endourol. 2010;24(10):1583–8.
Grasso M, Conlin M, Bagley D. Retrograde ureteropyeloscopic treatment of 2 cm or greater upper urinary tract and minor staghorn calculi. J Urol. 1998;160:346–51.
Natalin R, Xavier K, Okeke Z, et al. Impact of obesity on ureteroscopic laser lithotripsy of urinary tract calculi. Int Braz J Urol. 2009;35(1):36–42.
Bultitude MF, Tiptaft RC, Dasgupta P, et al. Treatment of urolithiasis in the morbidly obese. Obes Surg. 2004;14(3):300–3004.
Nguyen TA, Belis JA. Endoscopic management of urolithiasis in the morbidly obese patient. J Endourol. 1998;12(1):30–5.
Best SL, Nakada SY. Flexible ureteroscopy is effective for proximal ureteral stones in both obese and nonobese patients: a two-year, single surgeon experience. Urology. 2011;77:36–9.
Dash A, Schuster TG, Hollenbeck BK, et al. Ureteroscopic treatment of renal calculi in morbidly obese patients: a stone-matched comparison. Urology. 2002;60:393–7.
Chung SY, Chon CH, Ng CS, et al. Simultaneous bilateral retrograde intrarenal surgery for stone disease in patients with significant comorbidities. J Endourol. 2006;20(10):761–5.
Flancbaum L, Choban PSA. Surgical implications of obesity. Annu Rev Med. 1998;49:215–34.
Pliskin MJ, Wikert GA, Dresner ML. Hemorrhagic complications of extracorporeal shock wave lithotripsy in an anticoagulated patient. J Endourol. 1989;3:405–9.
Ruiz H, Saltzman B. Aspirin-induced bilateral renal hemorrhage, after extracorporeal shock wave lithotripsy therapy: implicatiosn and conclusions. J Urol. 1990;143:791–2.
Klingler HC, Kramer G, Lodde M, et al. Stone treatment and coagulopathy. Eur Urol. 2003;43:5–9.
Kuo RL, Aslan P, Fitzgerald KB, et al. Use of ureteroscopy and Holmium:YAG laser in patients with bleeding diatheses. Urology. 1998;52:609–13.
Turna B, Stein RJ, Smaldone MC, et al. Safety and efficacy of flexible ureterorenoscopy and Holmium:YAG lithotripsy for intrarenal stones in anticoagulated cases. J Urol. 2008;179:1415–9.
Watterson JD, Girvan AR, Cook AJ, et al. Safety and efficacy of Holmium:YAG laser lithotripsy in patients with bleeding diatheses. J Urol. 2002;168:442–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hyams, E.S., Matlaga, B.R. (2013). Medical Comorbidities: Anticoagulation and Obesity. In: Monga, M. (eds) Ureteroscopy. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-206-3_35
Download citation
DOI: https://doi.org/10.1007/978-1-62703-206-3_35
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-205-6
Online ISBN: 978-1-62703-206-3
eBook Packages: MedicineMedicine (R0)